RLFTD Stock Price, News & Analysis
RLFTD
Company Description
Relief Therapeutics Holding SA (RLFTD), a biopharmaceutical company, focuses on providing innovative treatment options for select specialty and rare diseases. The company is committed to delivering transformative outcomes to benefit patients suffering from various conditions. Relief Therapeutics' portfolio includes revenue-generating products, proprietary drug delivery platform technologies, and a clinical development pipeline targeting rare metabolic, dermatology, and respiratory diseases. Recently, the company announced exclusive distribution agreements, financial results, and corporate updates.
Stock Performance
Latest News
SEC Filings
No SEC filings available for RLFTD.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the market cap of RLFTD (RLFTD)?
The market cap of RLFTD (RLFTD) is approximately 44.9M. Learn more about what market capitalization means .
What is Relief Therapeutics?
Relief Therapeutics is a biopharmaceutical company focused on providing innovative treatment options for select specialty and rare diseases.
What does Relief Therapeutics offer in its portfolio?
Relief Therapeutics' portfolio includes revenue-generating products, proprietary drug delivery platform technologies, and a clinical development pipeline targeting rare metabolic, dermatology, and respiratory diseases.
What recent announcements has Relief Therapeutics made?
Relief Therapeutics recently announced exclusive distribution agreements, financial results, and corporate updates.